Single-use Versus Reusable Gastroscopes in Patients With Upper Gastrointestinal Bleeding.

NCT ID: NCT06192355

Last Updated: 2024-01-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-27

Study Completion Date

2025-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Controlled-randomized trial evaluating single-use versus reusable gastroscopes in patients with upper gastrointestinal bleeding.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Acute upper gastrointestinal bleeding is a common medical emergency. According to guidelines, endoscopic evaluation should be performed within 24 hours. With an overall high incidence and an overall high number of diagnostic and therapeutic endoscopic procedures, the introduction of new endoscopic concepts may have a profound impact on outcomes as well as cost-effectiveness in upper gastrointestinal bleeding. For this purpose, the use of single-use gastroscopes represents an interesting possibility. Hygiene issues in the emergency situation are also relevant. The previous feasibility study One-Scope I demonstrated that the diagnosis as well as the therapy of upper gastrointestinal bleeding is possible with single-use gastroscopes. In this follow-up study, the investigators compare the use of single-use versus reusable gastroscopes in participants with suspected upper gastrointestinal bleeding in a randomized controlled trial.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Upper Gastrointestinal Bleeding

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single-use gastroscope

A disposable endoscope designed for a one-time use during a Gastroscopy, eliminating the need for reprocessing or sterilization. After a single procedure, the entire gastroscope is discarded, reducing the risk of cross-contamination and ensuring a fresh, sterile instrument for each patient intervention

Group Type EXPERIMENTAL

Endoscopic hemostasis using a Esophagogastroduodenoscopy

Intervention Type DEVICE

performing an Esophagogastroduodenoscopy for diagnosis and therapy of possible bleeding sites

reusable gastroscope

A durable endoscope designed for multiple uses after thorough reprocessing and sterilization

Group Type ACTIVE_COMPARATOR

Endoscopic hemostasis using a Esophagogastroduodenoscopy

Intervention Type DEVICE

performing an Esophagogastroduodenoscopy for diagnosis and therapy of possible bleeding sites

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Endoscopic hemostasis using a Esophagogastroduodenoscopy

performing an Esophagogastroduodenoscopy for diagnosis and therapy of possible bleeding sites

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Glasgow-Blatchford score (GBS) \>2
* Clinical signs of upper bleeding

Exclusion Criteria

* pregnancy
* Unable to provide consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital Augsburg

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christoph Römmele, MD

Role: PRINCIPAL_INVESTIGATOR

Unervsity Hospital Augsburg

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital of Augsburg

Augsburg, Bavaria, Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Christoph Römmele, MD

Role: CONTACT

+498214002351

Alanna Ebigbo, MD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Christoph Römmele, MD

Role: primary

+498214002351

Alanna Ebigbo, MD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

00000013

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Transnasal and Oral Gastroscopy.
NCT00273117 TERMINATED
Gastric Ultrasound Versus Gastroscopic Aspiration
NCT07292935 NOT_YET_RECRUITING NA